Study to Explore the Effect of Secukinumab, Compared to Placebo, on Fat Tissue and Skin in Plaque Psoriasis Patients
Clinical trial NCT03055494 · COMPLETED
Trial details
- NCT number
- NCT03055494
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-18
- Primary completion
- 2018-04-25
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.